cbdMD, Inc. (YCBD) Downgraded to Hold by Maxim Group

Market Context

cbdMD, Inc. operates in the Healthcare sector. The stock currently trades at $0.47 with a market capitalization of $5.6M. The stock has declined 45.5% over the past 52 weeks.

Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Maxim Group's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for cbdMD, Inc.

Among the 10 most recent ratings: 4 Buy, 6 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 17, 2026	Maxim Group	Hold	N/A
Aug 20, 2025	Maxim Group	Buy	N/A
May 22, 2025	Maxim Group	Buy	N/A
Oct 05, 2023	Maxim Group	Buy	N/A
Jun 18, 2021	Cantor Fitzgerald	Neutral	N/A

Related Tools: Analyst Ratings Dashboard | View YCBD Stock Page